https://www.selleckchem.com/pr....oducts/eprosartan-me
BChe levels were lower in OSCC (2940.32-1405.50 u/l when compared with controls (11149.60-11243.07 unit/l) and this difference was statistically significant. Postoperatively at 3 months, the serum BChe levels of OSCC patients increased almost two-fold compared to the preoperative values, and this difference was also statistically significant (P = 0.00 After 6 months, these levels further increased but did not reach those of controls. BChe can be used as an inexpensive, easy to use, noninvasive biomarker for the evaluation
Like
Comment
Share
